Apr 30 |
Eli Lilly's GLP-1 demand drives up stock price post Q1 results
|
Apr 30 |
US STOCKS-Wall St falls in lead up to Fed verdict after hot labor costs data
|
Apr 30 |
Pre-Markets Sell on Last Trading Day of April
|
Apr 30 |
Stocks to Watch Tuesday: PayPal, Eli Lilly, 3M, McDonald's
|
Apr 30 |
Lilly (LLY) Reports Q1 Earnings: What Key Metrics Have to Say
|
Apr 30 |
US STOCKS-Wall St set to open lower on economic data; Fed verdict on tap
|
Apr 30 |
Eli Lilly raises guidance on weight loss momentum
|
Apr 30 |
Eli Lilly in charts: Mounjaro, Zepbound, Verzenio, and Jardiance drive revenue growth in Q1; Trulicity declines 26%
|
Apr 30 |
Wall Street On Edge Ahead Of Fed Decision, Spotlight Falls On Amazon And AMD Earnings: Analyst Says Stocks Survive 'Fragility Test' As April Ends
|
Apr 30 |
Eli Lilly Non-GAAP EPS of $2.58 beats by $0.09, revenue of $8.77B misses by $160M
|